Blog: Blog2

GPCR News

Mar 31, 20221 min read

Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering

April 2022 "SAN DIEGO, April 12, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused...